To date, high expression of SATB1 has been linked to the progression of human gastric cancer[10-12], ovarian carcinoma[13], liver cancer[14-16], rectal cancer[17,18], laryngeal squamous cell carcinoma[19], cutaneous malignant melanoma[20], and prostate cancer[21,22]. Here, SATB1 is linked to prostate cancer.